Dr. Ayan Kusari, MD

Dr. Kusari practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Kusari's NPI, 1295295764, was assigned on March 21, 2019. Dr. Kusari graduated from UC San Diego School of Medicine in 2019. Dr. Kusari holds California license A181659.

Dr. Kusari's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Kusari's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Kusari to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kusari practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Kusari's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kusari is board certified in dermatology by the American Board of Dermatology. Dr. Kusari is licensed in California.

CMS data shows 922 Medicare services from Dr. Kusari across 13 procedure codes in 2024, for 176 Medicare patients. Medicare paid $112,147 for them. Every service was in an office.

CMS counts 176 Medicare patients who saw Dr. Kusari in 2024. The largest group is 65 to 74, with 75 patients. 65% of them have high cholesterol, and 64% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kusari's median patient age at 50, with 55% women.

In 2024, Dr. Kusari wrote 181 Medicare Part D claims for 90 patients. 87% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $319 in total drug cost. In 2023, CMS named 188 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Kusari for performance year 2024, reported as part of a group. Dr. Kusari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kusari as offering telehealth. CMS counts 58 procedures of melanoma (skin cancer) excision by Dr. Kusari, more than 88% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Kusari, published from 2018 to 2023. 2018 was the busiest year, with 5. The most frequent topics are Infant, Premature and Skin. Dr. Kusari has published most often in Pediatr Dermatol. Dr. Kusari's most frequent co-authors are Lawrence F. Eichenfield, MD, Allison Mary Han, MD and Jusleen Ahluwalia, MD.

Dmand AI links Dr. Kusari to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Condylomata Acuminata and Warts.

CMS Open Payments shows 6 general payments to Dr. Kusari from 2 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $325. It also lists 1 research payment totaling $1,900 in 2022.

Dr. Kusari graduated from UC San Diego School of Medicine in 2019.

Dr. Kusari is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.